Dr. Shweta Bansal, MD

Dr. Bansal practices at University Hospital (San Antonio) in San Antonio, Texas.

Dr. Bansal's NPI, 1215083894, was assigned on January 26, 2007. Dr. Bansal graduated from Sawai Man Singh Medical College in 1998. Dr. Bansal holds Texas license N2394.

Dr. Bansal's primary practice is University Hospital (San Antonio), at 4502 Medical Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 358-4000.

Dr. Bansal's primary practice is University Hospital (San Antonio) in San Antonio, Texas. Dr. Bansal is also affiliated with University Hospital. The medical group on file is University Medicine Associates. Dmand AI also links Dr. Bansal to 1 more hospital, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bansal practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bansal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bansal is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Bansal's licenses on file in 2 states: Texas and Colorado.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Bansal treats.

CMS data shows 366 Medicare services from Dr. Bansal across 8 procedure codes in 2024, for 119 Medicare patients. Medicare paid $40,058 for them.

CMS counts 119 Medicare patients who saw Dr. Bansal in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bansal's median patient age at 65, with 48% women.

In 2024, Dr. Bansal wrote 667 Medicare Part D claims for 104 patients. 86% of them were for generic drugs. CMS names the drug for 495 of them, across 22 drugs with 11 or more claims each, at $72,328 in total drug cost. In 2023, CMS named 308 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Bansal for performance year 2024, reported as part of a group. Dr. Bansal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 115 papers to Dr. Bansal, published from 2007 to 2025. 2020 was the busiest year, with 19. The most frequent topics are Communicable Diseases, Disease Outbreaks and Models, Biological. Dr. Bansal has published most often in PLoS Comput Biol. Dr. Bansal's most frequent co-authors are Anand Prasad, MD, Paolo Fanti, MD and Kumar Sharma, MD.

Dmand AI links Dr. Bansal to 2 clinical trials. Conditions studied include Cardio-Renal Syndrome, Hypertension, Pulmonary and Hypertension.

CMS Open Payments shows 139 general payments to Dr. Bansal from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $24,087. It also lists 2 research payments totaling $162 from 2016 to 2017.

Dmand AI lists 2 awards for Dr. Bansal, most recently Robert Kunau Excellence in Teaching Awars in 2017.

Dr. Bansal graduated from Sawai Man Singh Medical College in 1998. Dr. Bansal is a member of ASN.

Dr. Bansal is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.